Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain - Fox Business

1. Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain  Fox Business
2. BioNTech testing Pfizer COVID-19 vaccine against B.1.1.529 variant  Business Insider
3. Merck says its Covid antiviral treatment less effective than first thought  Financial Times
4. BioNTech says it will know vaccine's effectiveness against new variant in two weeks | TheHill  The Hill
5. With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan  RealMoney
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/315y47e